Researcher
Kevin Braeckmans
- Keywords:nanomedicines, biophotonics, medical nanotechnology, drug delivery, microscopy
- Disciplines:Nanobiotechnology, Nanoscale characterisation, Nanophotonics, Nanometrology, In vitro testing, Biopharmaceuticals, Non-clinical studies, Nanomaterials, Medical nanotechnology, Biopharmaceutics, Physical pharmacy
Affiliations
- Department of Pharmaceutics (Department)
Member
From1 Aug 1999 → Today
Infrastructure
1 - 4 of 4
- Flanders BioImaging (Consortium partner)
- A multimodal non-linear optical platform for 2l3-photon excitation and 2ndl3rd harmonic imaging deep inside living tissues and animals (Consortium partner)
- Confocal and two-photon Microscope (Consortium coordinator)
- Stimulated Emission Depletion Microscope (Consortium coordinator)
Projects
1 - 10 of 56
- Engineering of universal iPSC-derived therapeutic cells by nanofiber photoporation.From1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- Analysis and prevention of protein particle formation – An approach towards safer antibody drugs in the clinicFrom1 Nov 2023 → TodayFunding: FWO Strategic Basic Research Grant
- Engineering of universal iPSC-derived therapeutic cells by nanofiber photoporation.From1 Oct 2023 → 31 Oct 2023Funding: BOF - doctoral mandates
- Uncovering the mechanism underlying and consequences of alphaherpesvirus-induced formation of tunneling nanotubes (TNTs)From1 Oct 2023 → TodayFunding: BOF - doctoral mandates
- Flanders BioImaging: Leading Imaging Application Integrated Service and Enablement (FBI-LIAISE)From1 Jan 2023 → TodayFunding: FWO International research infrastructure (IRI)
- Evaluation of cellular dynamics using automated widefield imagingFrom15 Dec 2022 → TodayFunding: BOF - scientific equipment program
- Single-cell ICP-mass spectrometry in the biological sciences: on the way to real-world useFrom1 Nov 2022 → 31 Dec 2022Funding: FWO senior postdoctoral fellowship
- NOn-VIral gene modified STEM cell therapyFrom1 Nov 2022 → TodayFunding: HORIZON.3.1 - European Innovation Council (EIC)
- Selective photoporation of the nuclear envelope to mimic pathological defects and facilitate intranuclear delivery.From1 Oct 2022 → TodayFunding: BOF - mobility
- Cofunding core facility - Ghent Light Microscopy (GLiM)From1 Jul 2022 → TodayFunding: BOF - research organisations
Publications
191 - 200 of 235
- siRNA and pharmacological inhibition of endocytic pathways to characterize the differential role of macropinocytosis and the actin cytoskeleton on cellular uptake of dextran and cationic cell penetrating peptides octaarginine (R8) and HIV-Tat(2012)
Authors: M. Al Soraj, L. He, Karen Peynshaert, J. Cousaert, Dries Vercauteren, Kevin Braeckmans, Arwin T. Jones
Pages: 132 - 141 - Intracellular partitioning of cell organelles and extraneous nanoparticles during mitosis(2012)
Authors: Nathalie Symens, Stefaan Soenen, Joanna Rejman, Kevin Braeckmans, Katrien Remaut
Pages: 78 - 94 - Investigating the toxic effects of iron oxide nanoparticles(2012)
Authors: Stefaan Soenen, Marcel De Cuyper, Stefaan De Smedt, Kevin Braeckmans, N Duzgunes
Pages: 195 - 224 - Limitations and caveats of magnetic cell labeling using transfection agent complexed iron oxide nanoparticles(2012)
Authors: Stefaan Soenen, Kevin Braeckmans
Pages: 140 - 152 - Development of a method for the measurement of primary cilia length in 3D(2012)
Authors: Taryn Saggese, Alistair A Young, Chaobo Huang, Kevin Braeckmans, Susan R McGlashan
- The cytotoxic effects of polymer-coated quantum dots and restrictions for live cell applications(2012)
Authors: Stefaan Soenen, Kevin Braeckmans
Pages: 4882 - 4888 - Immobilization of pseudorabies virus in porcine tracheal respiratory mucus revealed by single particle tracking(2012)
Authors: Xiaoyun Yang, Katrien Forier, Lennert Steukers, Sandra Van Vlierberghe, Kevin Braeckmans, Sarah Glorieux, Hans Nauwynck
- Hemocompatibility of siRNA loaded dextran nanogels(2011)
Authors: Broes Naeye, Hendrik Deschout, Magnus Roding, Mats Rudemo, Kevin Braeckmans, Koen Raemdonck
Pages: 9120 - 9127 - Effect of a low concentration of a cationic steroid antibiotic (CSA-13) on the formation of a biofilm by Pseudomonas aeruginosa(2011)
Authors: C Nagant, Y Feng, Bart Lucas, Kevin Braeckmans, P Savage, JP Dehaye
Pages: 763 - 772 - MRI assessment of blood outgrowth endothelial cell homing using cationic magnetoliposomes(2011)
Authors: Stefaan Soenen, Simon De Meyer, Tom Dresselaers, Greetje Vande Velde, Inge Pareyn, Kevin Braeckmans, Marcel De Cuyper, Uwe Himmelreich, Karen Vanhoorelbeke
Pages: 4140 - 4150
Patents
1 - 9 of 9
- Composition comprising at least one nanobomb suitable for altering a biological barrier (Inventor)
- Composition for treatment of vitreous disease or disorder (Inventor)
- Method to increase the permeability of the plasma membrane of cells and a structure suitable for use in such method (Inventor)
- Method and device to provide a microfluidic flow (Inventor)
- Method and system for characterizing extracellular vesicles (Inventor)
- Composition comprising at least one nanobomb suitable for altering a biological barrier (Inventor)
- Composition for treatment of vitreous disease or disorder (Inventor)
- Method and system for characterizing extracellular vesicles (Inventor)
- Method and system for dispersion measurements (Inventor)